Lotus Pharm vs Vetnostrum: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and Vetnostrum (6936) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ Vetnostrum

0%+226%-22%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYVetnostrumYoY
Oct 2026NT$2.13 billion-22.5%NT$134.8 million+13.8%
Sep 2026NT$2.77 billion+128.0%NT$116.4 million-6.9%
Aug 2026NT$2.11 billion+81.7%NT$113.8 million-6.2%
Jul 2026NT$2.49 billion+3.9%NT$145.6 million+13.1%
Jun 2026NT$3.4 billion+225.5%NT$117.3 million-0.4%
May 2026NT$2.32 billion+105.8%NT$126.1 million+19.3%
Apr 2026NT$3.09 billion+19.9%NT$132.3 million+27.2%
Mar 2026NT$4.35 billion+173.6%NT$132.3 million+15.7%
Feb 2026NT$2.24 billion+131.5%NT$92.3 million-11.7%
Jan 2026NT$2.05 billion-5.5%NT$143.8 million+18.1%
Dec 2025NT$2.44 billion+66.9%NT$120.1 million-3.8%
Nov 2025NT$1.06 billion-0.2%NT$134.1 million+41.2%
Oct 2025NT$2.75 billion+46.0%NT$118.4 million+12.0%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16